China’s new cancer drug Toripalimab is approved in the US but will cost 30 times more
China’s new cancer drug Toripalimab is approved in the US but will cost 30 times more
www.scmp.com
US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval
Cheap R&D overseas and reap the profits in the US. It’s the new norm for capitalism